Douglas Blankenship

Overview

Douglas Blankenship received $2M in total compensation, including $209K in salary, at Dova Pharmaceuticals in 2017.

Source: SEC filing on April 27, 2018.

Related executives

We found five more executives who work or worked at Dova Pharmaceuticals.

Mark Hahn

Dova Pharmaceuticals

Chief Financial Officer

David Zaccardelli

Dova Pharmaceuticals

Chief Executive Officer

Kevin Laliberte

Dova Pharmaceuticals

Senior Vice President, Product Development

Alex Sapir

Dova Pharmaceuticals

Chief Executive Officer

Lee Allen

Dova Pharmaceuticals

Chief Medical Officer

You may also like